TRAXV
NASDAQFirst Tracks Biotherapeutics Inc.
SectorHealth CareIndustryBiotechnology: Pharmaceutical Preparations
News2/Ratings0
News · 26 weeks20%
2025-12-212026-06-14
Mix290d
- SEC Filings2(100%)
Latest news
2 items- SECFirst Tracks Biotherapeutics Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders, Entry into a Material Definitive Agreement, Changes in Control of Registrant, Other Events8-K - First Tracks Biotherapeutics, Inc. (0002091349) (Filer)
- SECSEC Form S-8 filed by First Tracks Biotherapeutics Inc.S-8 - First Tracks Biotherapeutics, Inc. (0002091349) (Filer)
TRAXV FAQ
4 questionsWhere does TRAXV stock trade?
First Tracks Biotherapeutics Inc. (TRAXV) is listed on NASDAQ.What sector and industry is TRAXV in?
First Tracks Biotherapeutics Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.What companies are similar to TRAXV?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), AZN (AstraZeneca PLC), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare TRAXV side-by-side with any of them on Quantisnow.How can I track TRAXV on Quantisnow?
Quantisnow aggregates First Tracks Biotherapeutics Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow TRAXV to receive live email and push alerts on every new disclosure.